GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Leadman Biochemistry Co Ltd (SZSE:300289) » Definitions » Gross-Profit-to-Asset %

Beijing Leadman Biochemistry Co (SZSE:300289) Gross-Profit-to-Asset % : 10.50% (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Beijing Leadman Biochemistry Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Beijing Leadman Biochemistry Co's annualized Gross Profit for the quarter that ended in Mar. 2024 was ¥201.8 Mil. Beijing Leadman Biochemistry Co's average Total Assets over the quarter that ended in Mar. 2024 was ¥1,922.5 Mil. Therefore, Beijing Leadman Biochemistry Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 10.50%.


Beijing Leadman Biochemistry Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Beijing Leadman Biochemistry Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Leadman Biochemistry Co Gross-Profit-to-Asset % Chart

Beijing Leadman Biochemistry Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.36 15.25 14.83 13.82 13.45

Beijing Leadman Biochemistry Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.40 13.69 13.27 15.05 10.50

Competitive Comparison of Beijing Leadman Biochemistry Co's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Beijing Leadman Biochemistry Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Leadman Biochemistry Co's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Beijing Leadman Biochemistry Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Beijing Leadman Biochemistry Co's Gross-Profit-to-Asset % falls into.



Beijing Leadman Biochemistry Co Gross-Profit-to-Asset % Calculation

Beijing Leadman Biochemistry Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=264.935/( (1999.821+1938.399)/ 2 )
=264.935/1969.11
=13.45 %

Beijing Leadman Biochemistry Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=201.792/( (1938.399+1906.544)/ 2 )
=201.792/1922.4715
=10.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Beijing Leadman Biochemistry Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Beijing Leadman Biochemistry Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Leadman Biochemistry Co (SZSE:300289) Business Description

Traded in Other Exchanges
N/A
Address
No.5 Hongda South Road, Beijing, CHN
Beijing Leadman Biochemistry Co Ltd is a biotechnology company based in China. The company is focusing on research and development, manufacture, and sales of in vitro diagnostic (IVD) products. The company has core competencies in biochemistry, in vitro diagnostic reagents and instruments. Its product offering includes biochemical raw materials such as enzymes, coenzymes, antibodies, buffers, and enzyme substrates; biochemistry diagnostic and companion reagents; and medical test instruments.

Beijing Leadman Biochemistry Co (SZSE:300289) Headlines

No Headlines